Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-28
2006-03-28
Chang, Celi (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S187000
Reexamination Certificate
active
07019017
ABSTRACT:
Peptide mimetic small molecule inhibitors of Sur-2 are provided having the general formula:
REFERENCES:
patent: 5019660 (1991-05-01), Chapman et al.
patent: 5053434 (1991-10-01), Chapman
patent: 5786379 (1998-07-01), Bernardon
patent: 5854245 (1998-12-01), Duggan et al.
patent: 5877342 (1999-03-01), Bernardon et al.
patent: 6127415 (2000-10-01), Pfahl et al.
patent: 6462064 (2002-10-01), Pfahl et al.
Asada et al. “A genepexpression inhibitor . . . ” CA 138:363718 (2003).
H. Roh et al.; HER2
euy antisense targeting of human breat carcinoma; Oncogene 19, 2000; 6138-6143.
S. Chiang et al, “Targeting the Ets Binding Site of the HER2
eu Promoter with Pyrrole-Imidazole Polyamides,” The Journal of Biological Chemistry vol. 275, No. 32, Issue of Aug. 11, 2000, pp. 24246-24254.
H. Roh, “Down-Regulation of HER2
eu Expression Induces Apoptosis in Human Cancer Cells That Overexpress HER2
eu,” Cancer Research 60, Feb. 1, 2000, pp. 560-565.
R. Redline et al., “Placental Lesions Associated with Cerebral Palsy and Neurologic Impairment Following Term Birth,” Archivers of Pathology and LAboratory Medicine vol. 124, Dec. 2000, pp. 1785-1791.
S. Asada et al., “External Control of Her2 Expression and Cancer Cell Growth by Targeting a Ras-linked Coactivator,” PNAS vol. 99 No. 20, Oct. 1, 2002, pp. 12747-12752.
S. Asada et al., “A Gene-Expression Inhibitor that Tergets an a-Helix-Mediated Protein Interaction,” Journal American Chemical Society vol. 125, No. 17, 2003, pp. 4992-4993.
U.S. Appl. No. 10/770,303, filed Feb. 2, 2004.
H. Shimogawa et al., “A Wrench-Shaped Synthetic Molecule that Modulates a Transcription Factor—Coactivator Interaction”, J. Am. Chem. Soc. 2004, 126, 3461-3471.
Asada Shinichi
Uesugi Motonari
Baylor College of Medicine
Chang Celi
Fulbright & Jaworski LLP
LandOfFree
Small molecule inhibitors of HER2 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small molecule inhibitors of HER2 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule inhibitors of HER2 expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3584098